Axial Profile Banner
Axial Profile
Axial

@AxialXYZ

Followers
6,682
Following
10
Media
294
Statuses
1,745

Axial - agency for great inventors - info @axialvc .com

San Francisco, CA
Joined July 2019
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@AxialXYZ
Axial
5 years
Axial partners with great inventors.
3
14
118
@AxialXYZ
Axial
3 years
New frontiers #3 1. ADCs 2. Cultured meats 3. Phenotypic screening 4. Industrial enzymes 5. Chemokines 6. Building the US-version of WuXi 7. Infectious disease 8. Immunometabolism 9. Fast following in drug development 10. Single-cell sequencing
2
26
116
@AxialXYZ
Axial
2 years
Gerty and Carl Cori won the Nobel Prize for discovering the lactic acid cycle, known as the Cori Cycle. They advanced how the body produces & stores energy forming the basis for current diabetes treatments. And showing the clarity of chemistry can be used to unveil opaque biology
Tweet media one
3
18
85
@AxialXYZ
Axial
3 years
Congratulations to Aaron Ring @aaronmring on being named one of the top 20 translational researchers of 2020🎉He's just getting started. Founding @simchatx and @Seranova with more coming up, the Ring Lab will be a Golden Goose of great inventions & talent over the next decades
Tweet media one
2
21
76
@AxialXYZ
Axial
2 years
Prime Medicine $PRME just went public yesterday and is a fascinating case study given that the inventor, David Liu @davidrliu , is the largest shareholder at 24.79% before the offering. The company is pursuing a Moderna-like strategy to define & monopolize a new technology
Tweet media one
2
11
66
@AxialXYZ
Axial
3 years
Atlas, Bruce Booth @LifeSciVC , and everyone who has built up the biotech industry deserve a lot more respect than they’re getting. A founder-led model is about building something different but everyone is still trying to solve the same problems - help patients and our environment
3
8
69
@AxialXYZ
Axial
2 years
With @MargauxPinney , we discuss her journey to become a scientist & leader in her field and her work around enzyme evolution. By bringing quantitative, high-throughput assays to enzymes, the Pinney Lab investigates enzyme function at a scale beyond traditional biochemistry
Tweet media one
3
10
60
@AxialXYZ
Axial
2 years
Schrödinger sells physics-based software for drug discovery. With >$100M in annual revenue across >1K customers, the company is one of the most successful software companies in life sciences & used their own product to build a pipeline
Tweet media one
3
8
62
@AxialXYZ
Axial
2 years
Biotech's Most Successful Startups - @Ginkgo , one of the canonical synthetic biology companies of this era
Tweet media one
3
8
60
@AxialXYZ
Axial
2 years
Vicki Sato @VickiSato is a biotech legend currently serving as the chairwoman of Vir @Vir_Biotech among other boards. She has had an incredible career in biotech serving as the CSO then President of Vertex @VertexPharma , VP of Research early on at Biogen, & a Professor at Harvard
Tweet media one
4
7
54
@AxialXYZ
Axial
10 months
Each version of CRISPR builds upon the last. Work between 2012-2016 dealt with effector selection & corresponding PAM compatibility CRISPR = Clustered Regularly Interspaced Short Palindromic Repeats is actually a defense system against bacteriophages And has two major classes:
Tweet media one
3
10
48
@AxialXYZ
Axial
2 years
Bryan Dickinson @chembioBryan is a professor at UChicago building new chemical tools to control biology. In our podcast conversation, we discuss everything from directed evolution and drugging RNA to what it takes to start a lab
Tweet media one
5
5
47
@AxialXYZ
Axial
3 years
🤯the blueprint (mRNA) is larger than the object (protein) it encodes for
Tweet media one
0
4
42
@AxialXYZ
Axial
2 years
Oxford Nanopore @nanopore sequences DNA with a nanopore. Founded in 2005 out of Oxford, they productized decades of research & launched MinION in 2014/2015; I remember using it for an early-access program. Now they are moving into long-read & expanding surveillance applications
Tweet media one
2
10
41
@AxialXYZ
Axial
2 years
LatchBio @LatchBio has built one of the best software products in life sciences, providing infrastructure for scientists to store, process, and visualize their data. Founded in 2021 in by @AlfredoAndere , @kylegiff , and @kenbwork , Latch always ships product & talks to customers
Tweet media one
1
9
38
@AxialXYZ
Axial
2 years
Living Carbon @living_carbon founded in 2019 by Maddie Hall @maddiehalla engineers trees to enhance carbon capture & storage, designing trees and selling carbon credits. Over 1.5B trees are planted per year in the US & offer a clear way sequester gigatons of carbon
Tweet media one
5
8
34
@AxialXYZ
Axial
2 years
ChemoCentryx was acquired by Amgen for ~$3.8B in 2022. Founded in 1996, by Thomas Schall who discovered many of the 50 chemokines, the company was started to drug them, the trafficking control system for immune system & develop once-daily, orally-available drugs for autoimmunity
Tweet media one
1
8
37
@AxialXYZ
Axial
1 year
Drugs that are their own pipelines
Tweet media one
3
3
37
@AxialXYZ
Axial
1 year
Biologics represent >$200B in annual sales. This has given space for unique business models that act as service providers to grow to billion-dollar companies from Abimab to AbCellera. Now with >100 antibody discovery service companies out there the market is increasingly crowded
Tweet media one
1
11
36
@AxialXYZ
Axial
2 years
Resilience @IncResilience is leading the way to onshore biomanufacturing to the US. Founded in 2020 by Bob Nelsen @rtnarch after frustrated with the COVID response & led by Rahul Singhvi @rsinghvi , Resilience with an end-to-end model, is reimagining how complex medicines are made
Tweet media one
1
7
28
@AxialXYZ
Axial
1 year
Adimab model for RNA RNA therapeutics are beginning to have repeatable success in the clinic. With RNAi taking the lead in terms of approvals. However, IP for chemical modifications, delivery, formulation are becoming (temporary) barriers for new entrants.
Tweet media one
1
11
31
@AxialXYZ
Axial
1 year
Proteomics is filling out the picture of biology after ~2 decades of the genomic era Moore’s-like law advances in LC/MS as well as single-cell proteomics is leading to a more biochemically sound understanding of proteins across all scales from organs/tissues to cells
Tweet media one
1
5
33
@AxialXYZ
Axial
3 years
Founder-led life sciences companies for the win🏆
@qcapital2020
 Q-Cap 
3 years
Founder-led Stocks > Non Founder-led Source: Bain & Company
Tweet media one
44
285
1K
1
12
34
@AxialXYZ
Axial
1 year
Genomics for target identification. Proteomics for target validation. Until a dataset comparing protein expression/proteoforms in disease across enough people, using proteomics for drug development might be more impactful to selling the proteomics tool itself.
Tweet media one
1
6
27
@AxialXYZ
Axial
3 years
Axial is very excited to launch the BioBuilder Jobs Board - Please RT to make sure as many founders and scientists see 🙌🎉
1
15
32
@AxialXYZ
Axial
2 years
Really excited to put out a recent conversation with Hannes Stärk @HannesStaerk on the Axial podcast discussing his journey from Munich to MIT and research on graph machine learning for protein and small molecule design. Find it on Anchor:
Tweet media one
1
3
32
@AxialXYZ
Axial
2 years
LanzaTech @LanzaTech is building a next-generation refinery to produce low carbon products. Founded in 2005 from a research paper found in a library, the company uses microbes to convert industrial gas into fuels & create a series of low-carbon products
Tweet media one
3
5
32
@AxialXYZ
Axial
1 year
Transferrin receptor (TfR) is currently the main shuttle for large molecules into the brain With only ~0.1% of biologics crossing the BBB from blood. With ~2 decades of work on TfR delivery, why has Denali Therapeutics essentially leapfrogged everyone else?
Tweet media one
1
7
32
@AxialXYZ
Axial
2 years
Debut @Debut_Biotech uses cell-free biomanufacturing for ingredients, chemicals, and more. Founded in 2019, by Joshua Britton, Brady Beauchamp, and Greg Weiss, Debut focuses on using biotech to build brands. With a fully-integrated platform & various partnerships in health/food
Tweet media one
1
6
24
@AxialXYZ
Axial
2 years
Dyno @Dyno_Tx was founded by Eric Kelsic @ekelsic , Adrian Veres @AdrianVeresBio , Sam Sinai @samsinai , George Church @geochurch , & Alan Crane in 2018 to bring machine learning to AAV gene therapies. Doing an incredible job building their platform & getting partners on board
Tweet media one
3
4
29
@AxialXYZ
Axial
5 months
We see a need for patent management software designed for inventors and using LLMs to create better patents, automate lifecycle work, and overall, make patents less painful for inventors
Tweet media one
2
7
29
@AxialXYZ
Axial
3 years
5 unsolved mysteries of the brain 🧠 1. What is the brain made of? 2. How does the brain change in disease? 3. How do neurons talk to each other? 4. How does the brain compute? 5. What will it mean to understand our brains?
Tweet media one
1
7
29
@AxialXYZ
Axial
3 years
There’s a large opportunity to transform linker design from trial-and-error to a rational process. First starting with PROTACs (with @ArvinasInc as the 1st mover) then expanding to ADCs, bispecifics, and bridging any molecule
1
8
29
@AxialXYZ
Axial
2 years
Arbor Biosciences @ArborBio is commercializing the myTXTL cell-free expression kit. Founded in 2006 out of the University of Michigan by Erdogan Gulari & Jean-Marie Rouillard to serve their scientific peers with new reagents. Growing from sequencing panels to protein expression
Tweet media one
1
5
25
@AxialXYZ
Axial
2 years
Abcam @abcam was founded in 1998 by Jonathan Milner with Tony Kouzarides & David Cleevely to build a marketplace for antibodies. Milner was a postdoctoral fellow in the Kouzarides Lab at Cambridge where his project was slowed down by the lack of high-quality antibody reagents
Tweet media one
3
3
18
@AxialXYZ
Axial
2 years
Ablynx @AblynxNV pioneered nanobodies, got acquired for €3.9B by @sanofi in 2018, and might have massively undersold itself. Founded in 2001 based on research out of Brussels, the company can trace its origins back to a Moroccan camel in the 1990s to a drug approval in 2019
Tweet media one
1
7
26
@AxialXYZ
Axial
1 year
Nimbus @NimbusTx : - Founded in 2009 by Atlas & Schrödinger - Combining computational chemistry with a capital efficient business model - Selling a NASH asset to Gilead in 2016 for ~$400M - Selling a TYK2 inhibitor to Takeda in 2022 for ~$4B - Still controlling their own destiny
Tweet media one
0
5
26
@AxialXYZ
Axial
1 year
Bicycle Therapeutics @Bicycle_tx develops bicyclic peptides into drugs. Founded in 2009 by Gregory Winter, who invented phage display, the company has brought this new modality ('bicycles') in the clinic to treat cancer.
Tweet media one
1
4
27
@AxialXYZ
Axial
2 years
CambridgeSoft commercialized ChemDraw @ChemDraw & revolutionized how chemistry is communicated. Before ChemDraw, every chemist needed a drafting board. Now used by >1M people, ChemDraw was invented by Sally Evans after hours of frustration drawing chemical structures by hand
Tweet media one
1
8
26
@AxialXYZ
Axial
1 year
Crossing the BBB (blood-brain barrier) Development of therapies to treat CNS diseases, especially large molecules like antibodies, is limited by the BBB. As the gatekeeper for the brain, the BBB separates the brain from circulating blood
Tweet media one
1
7
25
@AxialXYZ
Axial
2 years
Cryoport @cryoport is the leading biotech logistics company for cell therapies to immunotherapies & embryos. Founded in 1999, the company started off to replace dry ice shipping with a cryogenic flask. Now Cryoport generates >$200M in annual sales across 1000s of clients
Tweet media one
1
5
25
@AxialXYZ
Axial
1 year
Glycobiology in the clinic Glycans decorate every cell in the body. As well as most proteins and most recently found on RNA. Advances in glycoproteomics/chemical biology has led to several drug candidates in the clinic targeting glycosylation.
Tweet media one
1
7
25
@AxialXYZ
Axial
2 years
Congrats to @LabAlper , @at_lynd , & the Ellington and Zhang Labs on inventing, powered by ML, an enzyme that can break down PET plastics Axial is excited to partner with Aperiam Bio led by Austin Cole to develop next-gen bio-products using this technology
2
7
24
@AxialXYZ
Axial
2 years
PacBio @PacBio is the market leader for long-read sequencing. Founded in 2004, spun out of Cornell from research in the late 90s & incubated by Kleiner Perkins, PacBio (was Nanofluidics) increased the accuracy of sequencing a single molecule of DNA with their SMRT technology
Tweet media one
1
6
24
@AxialXYZ
Axial
11 months
RNA modifications have been historically considered to be relatively static fine-tuners of the RNA structure and function. However, it has become evident that the epitranscriptomic layer is not only dynamic and reversible - catalyzed by RNA modification “erasers” -
Tweet media one
1
3
19
@AxialXYZ
Axial
1 year
Illumina sales Illumina sales in year one: today: $474,000 $474,000 per hour
Tweet media one
Tweet media two
0
4
23
@AxialXYZ
Axial
1 year
Denali @Denalitx : - Founded in 2013 & led by Ryan Watts, former head of neuroscience at Genentech - Getting started with the largest biotech Series A at the time, >$200M - Drugging TREM2 for AD, RIPK1 from an M&A & building a unified neuro platform with their TfR delivery tech
Tweet media one
0
3
18
@AxialXYZ
Axial
2 years
EnginZyme @EnginZyme uses cell-free to produce chemicals without living cells. Founded in 2014 out of Sweden by Karim Engelmark Cassimjee, Robin Chatterjee, & Samuel Hargestam, the company creates new catalysts to convert renewable feedstocks into high-value chemicals & materials
Tweet media one
1
6
21
@AxialXYZ
Axial
2 years
Element Biosciences @ElemBio decentralizes sequencing. Founded in 2017 by Molly He @MollyminHe , Matt Kellinger, & Michael Previte after working together at Illumina, Element built a benchtop sequencer from the ground up centered around new chemistry to reduce reagent use by ~100x
Tweet media one
1
7
21
@AxialXYZ
Axial
2 years
DNA-encoded libraries (DEL) promised to bring a rational process to small molecule discovery. There have been many struggles over the last 2 decades with so much work left to be done. Time to get back to the lab.
Tweet media one
5
3
20
@AxialXYZ
Axial
1 year
Addgene is one of the most widely used products for scientists. Serving >100K scientists. Generating >$23M in annual sales. With their collection of ~131.8K plasmids from around 5K research labs. Along with their expanded product offering of AAVs, CRISPR reagents, and antibodies
Tweet media one
1
4
21
@AxialXYZ
Axial
2 years
Seagen @SeagenGlobal (started as Seattle Genetics) pioneered antibody-drug conjugates. Founded in 1997 to cure cancer with a large dose of skepticism, the company started work on CD30 that led to Adcetris for lymphomas, their 1st blockbuster & sparked 3 more approved medicines
Tweet media one
1
3
20
@AxialXYZ
Axial
2 years
Sutro Biopharma @SutroBio develops cancer drugs with cell-free technology. Founded in 2003 as Fundamental Applied Biology by James Swartz, a professor at Stanford & pioneer in cell-free, Sutro is a leader for site-specific conjugations for ADCs & more
Tweet media one
1
6
20
@AxialXYZ
Axial
9 months
The central dogma of molecular biology describes the flow of genetic information within biological systems. It was first formulated by Francis Crick in 1958 and later clarified in 1970. The dogma states that information flows from DNA to RNA to protein
Tweet media one
1
7
21
@AxialXYZ
Axial
2 years
Kymab was acquired by Sanofi for >$1B in 2021. It is a case study of developing drugs with high conviction despite patent challenges, competition in the clinic, & trailblazing a new MoA. Founded in 2010 out of Cambridge, UK, Kymab is also an example for every British biotech
Tweet media one
1
5
17
@AxialXYZ
Axial
9 months
Microscopy has been a driving force for breakthrough discoveries in biology from how cells divide to how proteins interact with each other. And it has historically attracted unique characters over the centuries like Antonie Van Leeuwenhoek, the Janssens, and Douglas Prasher
Tweet media one
1
2
18
@AxialXYZ
Axial
11 months
Uri Alon, Geometry of Phenotype Space
Tweet media one
0
3
15
@AxialXYZ
Axial
2 years
BioRender @BioRender , founded in 2017 & led by Shiz Aoki @ShizAoki , has grown into a market-leader for scientific illustrations. Improving scientific communication. Used seemingly by every immunologist & microbiologist, BioRender is a under-the-radar success story in biotech SaaS
Tweet media one
1
5
21
@AxialXYZ
Axial
2 years
Evotec @Evotec is a drug development partnering company, built mainly through trial-and-error. Evotec was founded in 1993 in Germany by Nobel Laureate Manfred Eigen (measuring chemical reactions), Charles Weissmann (cloning interferon) and a set of German entrepreneurs
Tweet media one
3
4
19
@AxialXYZ
Axial
1 year
Looking at clinical phase transitions from 2011-2020, it becomes abundantly clear that monoclonal antibodies (and maybe biologics in general) have a huge advantage over other drug modalities
Tweet media one
Tweet media two
1
5
21
@AxialXYZ
Axial
2 years
10X @10xGenomics created the single-cell sequencing market & enables the next century of discoveries in biology. Founded in 2012 by Serge Saxonov @saxonov , Ben Hindson, & Kevin Ness @kevin_dean_ness , were all at QuantaLife, 10X builds tools to measure biology at high resolution
Tweet media one
1
5
20
@AxialXYZ
Axial
2 years
Illumina @illumina enabled the genomics revolution. Founded in 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, & Mark Chee, their 1st product was a SNP genotyping service in 2001 then launching their microarray BeadLab instrument in 2002
Tweet media one
1
5
20
@AxialXYZ
Axial
2 years
Affinivax was acquired by @GSK in 2022 for $2.1B. Founded in 2014 out of Boston Children’s Hospital, Affinivax develops vaccines without adjuvants. The company was acquired mainly for its 24-valent pneumococcal vaccine in late-stage trials to go heads up against Pfizer/Prevnar
Tweet media one
1
5
20
@AxialXYZ
Axial
1 year
Fabric Genomics @FabricGenomics is a computational genomics company that provides end-to-end genomic data analysis, annotation, curation, classification, and reporting solutions. To clinical/hospital labs and life science companies.
Tweet media one
2
5
18
@AxialXYZ
Axial
10 months
Frontier Medicines. “I think 50–100 years from now, there will be no protein that is undruggable. Everything will be druggable." - Daniel Nomura, Co-Founder Frontier was founded in 2018 by Chris Varma, who was an EIR at MPM Capital, and Zoncu and Nomura
Tweet media one
1
6
19
@AxialXYZ
Axial
1 year
Aethon Therapeutics @AethonTx develops antibodies to help the immune system to find and kill persistent cancer cells. Founded in 2022, based on work from NYU Langone, the company's HapImmune platform uses covalent inhibitors to generate haptens targetable by antibodies.
Tweet media one
1
4
20
@AxialXYZ
Axial
1 year
Sano Genetics @sanogenetics is a data-sharing platform that enables its users to participate in research studies. Founded in 2017 to connect consumers and researchers to precision medicine research.
Tweet media one
1
4
19
@AxialXYZ
Axial
2 years
Tierra @tierrabio prints custom proteins using cell-free. Founded in 2015 by Zach Sun, the company unlocks new proteins for their users & lowers barriers for protein synthesis. As a platform for protein engineers, users can send up to 10K protein sequences & get custom proteins
Tweet media one
1
8
20
@AxialXYZ
Axial
2 years
Hexagon Bio @hexagonbio mines the global metagenome for new medicines. With one of the best engineering teams in biotech, Hexagon combines data science + genomics + synbio to scale & automate the discovery of natural products to drug the "undruggable" genome
Tweet media one
3
3
19
@AxialXYZ
Axial
2 years
Morphic @MorphicTx is a clinical-stage company developing small molecules to replace the multi-$B market of integrin targeting biologics. Founded in 2014 by @timothyspringer (discovered integrins), Morphic is taking on the daunting task of drugging specific states with oral drugs
Tweet media one
1
4
19
@AxialXYZ
Axial
2 years
Royalty Pharma $RPRX is the largest buyer of drug royalties in the world. Founded in 1996 by Pablo Legorreta @plegorreta , the company has deployed over $20B for >50 royalties on marketed medicines like Xtandi & Imbruvica. Generating over $2B in annual revenue
Tweet media one
3
5
17
@AxialXYZ
Axial
3 years
Eight Lessons from Alejandro Zaffaroni, a biotechnology pioneer. Initially working at Syntex, he founded a wide-range of companies: Alza in particular, which brought over 20 medicines to market and created an entire new category centered around drug delivery Thread below👇
Tweet media one
1
9
19
@AxialXYZ
Axial
2 years
Axial is excited to announce the first company in the Axial 22 class: Circos Health led by Stan Kwang. The company is building a precision medicine platform to scalably profile immune repertoires for monitoring and treatment of immune-related disease.
1
4
16
@AxialXYZ
Axial
2 years
@MyoKardia is one of the largest & rare success stories in cardiovascular drug development. Founded in 2012 & acquired by BMS in 2020 for >$13B, the company led by @tgianakakos pioneered a precision medicine approach in heart disease with a 2022 approval of mavacamten in HCM
Tweet media one
5
5
19
@AxialXYZ
Axial
4 years
Axial is building a new company in kidney disease. If you want to get involved to transform the lives of patients, apply here:
1
7
19
@AxialXYZ
Axial
2 years
Elektrofi @elektrofi , founded in 2016, is an odd biotech company with the ability to build a profitable & efficient business. Focused on drug formulation & delivery, Elektrofi enables subcutaneous delivery of mAbs and other large molecule drugs
Tweet media one
4
3
19
@AxialXYZ
Axial
2 years
Forge Biologics @ForgeBio is a gene therapy manufacturing, and therapeutics company based in Columbus, Ohio. Founded in 2020 & led by Tim Miller, Forge has built one of the largest AAV manufacturing facilities, with end-to-end production from 50L to 5K liters right in the Midwest
Tweet media one
1
6
17
@AxialXYZ
Axial
9 months
Antibody therapeutics have become a major class of biologics used to treat a wide range of diseases, particularly cancer: 1. Innovation in antibody formats and engineering is enabling improved efficacy and safety
Tweet media one
1
4
18
@AxialXYZ
Axial
2 years
Seven Powers in Life Sciences 1. Scale: lowering unit costs 2. Network: increased value per user 3. Counter-Positioning: new business model 4. Switching: product moat 5. Branding: product's history 6. Cornered Resources: scarce resource 7. Process Power: institutional knowledge
Tweet media one
3
4
18
@AxialXYZ
Axial
2 years
Codexis @CodexisInc uses directed evolution to design enzymes & improve sustainability. Founded in 2002 as a spinoff from Maxygen, Codexis makes enzymes for partners like Merck, Novartis & GSK. Getting to >$100M in sales, showing a path for other enzyme companies
Tweet media one
0
4
16
@AxialXYZ
Axial
3 years
Beautiful work 👏👏👏 @josephmreplogle @JswLab
@josephmreplogle
Joseph Replogle
3 years
I'm thrilled to share our latest work performing genome-scale Perturb-seq screens to explore a remarkable breadth of questions in genetics and cell biology (thread below). Congrats to Reuben Saunders, Tom Norman, and @JSWlab for co-leading this work.
11
162
519
1
8
17
@AxialXYZ
Axial
2 years
Tu Youyou is a chemist who won the Nobel Prize in 2015 for the discovery of artemisinin A medicine that has saved millions of lives for the treatment of malaria. All starting from ancient Chinese texts to screen >2K traditional recipes & ~380 extracts
Tweet media one
1
3
16
@AxialXYZ
Axial
10 months
Merck is one of the greatest drug companies ever. With one of the best selling medicines in the world the company can trace its roots to a small German pharmacy centuries ago. Roughly the Merck story can be divided into 6 major events/parts:
Tweet media one
2
5
18
@AxialXYZ
Axial
2 years
Benchling @benchling is leading the digitization of biotech. Founded & led by Sajith Wickramasekara @sajithw , the company started as a better plasmid editor & has grown into a unified R&D cloud for life sciences. Used by >200K scientists & 1000s of biotech companies/institutions
Tweet media one
1
6
18
@AxialXYZ
Axial
3 years
How successful drug companies closed their first deal? -
0
4
18
@AxialXYZ
Axial
1 year
BioNTech @BioNTech_Group : - Founded in 2008 out of Germany by Uğur Şahin, Özlem Türeci & Christoph Huber - Starting off with €150M in capital to develop mRNA-based individualized cancer immunotherapy - Shifting to COVID vaccines during the pandemic - Now going back to cancer/IO
Tweet media one
1
3
15
@AxialXYZ
Axial
1 year
Where can marketplaces succeed in biotech? For startups, it’s only really scaled in biologics with Abcam & now BenchSci. With high market concentration plus regulatory hurdles, biotech-specific marketplaces have been hard to build
Tweet media one
1
5
15
@AxialXYZ
Axial
2 years
Ultima Genomics @UltimaGenomics delivers the $100 genome. Founded in 2016 by Gilad Almogy & Mark Pratt @markrpratt , the company combines chemistry, ML, & fluidics to “drive down the cost of genomic information until it is routinely used in every part of the healthcare system”
Tweet media one
1
5
17
@AxialXYZ
Axial
3 years
There are 14 new job postings from really exciting companies like @GlyphicBio to @InscriptaInc and @Novozymes on the BioBuilder Jobs Board - Please RT to make sure as many founders and scientists see so they can post and see new job opportunities 🙏
2
10
18
@AxialXYZ
Axial
2 years
Solugen @solugen is working to become the Standard Oil of biology & help decarbonize the world along the way. Founded in 2016 by @GaurabC & @TungstenSeanide , the company sold hydrogen peroxide for hot tubs and even wipies before finding PMF for wastewater treatment
Tweet media one
3
3
18